• >>
  • Pharmaceuticals and Healthcare

COVID-19 Impact on Global Prescription Respiratory Drugs Market Insights, Forecast to 2026

ID: 1301383
24 July 2020
Region : Global
115 Pages
CHOOSE LICENCE TYPE

COVID-19


Understand the influence of COVID-19 on the Prescription Respiratory Drugs Market with our analysts monitoring the situation across the globe.






Description

A prescription drug is a pharmaceutical drug that legally requires a medical prescription to be dispensed. Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Prescription Respiratory Drugs market in 2020. COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future. This report also analyses the impact of Coronavirus COVID-19 on the Prescription Respiratory Drugs industry. Based on our recent survey, we have several different scenarios about the Prescription Respiratory Drugs YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Prescription Respiratory Drugs will reach xx in 2026, with a CAGR of xx% from 2020 to 2026. With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Prescription Respiratory Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Prescription Respiratory Drugs market in terms of both revenue and volume. Players, stakeholders, and other participants in the global Prescription Respiratory Drugs market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on sales (volume), revenue and forecast by each application segment in terms of sales and revenue and forecast by each type segment in terms of revenue for the period 2015-2026. Sales and Pricing Analyses Readers are provided with deeper sales analysis and pricing analysis for the global Prescription Respiratory Drugs market. As part of sales analysis, the report offers accurate statistics and figures for sales and revenue by region, by each type segment for the period 2015-2026. In the pricing analysis section of the report, readers are provided with validated statistics and figures for the price by players and price by region for the period 2015-2020 and price by each type segment for the period 2015-2020. Regional and Country-level Analysis The report offers an exhaustive geographical analysis of the global Prescription Respiratory Drugs market, covering important regions, viz, North America, Europe, China and Japan. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of sales for the period 2015-2026. Competition Analysis In the competitive analysis section of the report, leading as well as prominent players of the global Prescription Respiratory Drugs market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on sales by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020. On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Prescription Respiratory Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Prescription Respiratory Drugs market. The following manufacturers are covered in this report: AstraZeneca Boehringer Ingelheim GlaxoSmithKline Merck ... Prescription Respiratory Drugs Breakdown Data by Type Anti-Inflammatories Mast Stabilizers Antihistamines Bronchodilators Other Respiratory Drugs Prescription Respiratory Drugs Breakdown Data by Application Hospital Pharmacies Drug Stores Retail Stores E-Commerce

1 Study Coverage 1.1 Prescription Respiratory Drugs Product Introduction 1.2 Market Segments 1.3 Key Prescription Respiratory Drugs Manufacturers Covered: Ranking by Revenue 1.4 Market by Type 1.4.1 Global Prescription Respiratory Drugs Market Size Growth Rate by Type 1.4.2 Anti-Inflammatories 1.4.3 Mast Stabilizers 1.4.4 Antihistamines 1.4.5 Bronchodilators 1.4.6 Other Respiratory Drugs 1.5 Market by Application 1.5.1 Global Prescription Respiratory Drugs Market Size Growth Rate by Application 1.5.2 Hospital Pharmacies 1.5.3 Drug Stores 1.5.4 Retail Stores 1.5.5 E-Commerce 1.6 Coronavirus Disease 2019 (Covid-19): Prescription Respiratory Drugs Industry Impact 1.6.1 How the Covid-19 is Affecting the Prescription Respiratory Drugs Industry 1.6.1.1 Prescription Respiratory Drugs Business Impact Assessment - Covid-19 1.6.1.2 Supply Chain Challenges 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products 1.6.2 Market Trends and Prescription Respiratory Drugs Potential Opportunities in the COVID-19 Landscape 1.6.3 Measures / Proposal against Covid-19 1.6.3.1 Government Measures to Combat Covid-19 Impact 1.6.3.2 Proposal for Prescription Respiratory Drugs Players to Combat Covid-19 Impact 1.7 Study Objectives 1.8 Years Considered 2 Executive Summary 2.1 Global Prescription Respiratory Drugs Market Size Estimates and Forecasts 2.1.1 Global Prescription Respiratory Drugs Revenue 2015-2026 2.1.2 Global Prescription Respiratory Drugs Sales 2015-2026 2.2 Prescription Respiratory Drugs Market Size by Region: 2020 Versus 2026 2.2.1 Global Prescription Respiratory Drugs Retrospective Market Scenario in Sales by Region: 2015-2020 2.2.2 Global Prescription Respiratory Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020 3 Global Prescription Respiratory Drugs Competitor Landscape by Players 3.1 Prescription Respiratory Drugs Sales by Manufacturers 3.1.1 Prescription Respiratory Drugs Sales by Manufacturers (2015-2020) 3.1.2 Prescription Respiratory Drugs Sales Market Share by Manufacturers (2015-2020) 3.2 Prescription Respiratory Drugs Revenue by Manufacturers 3.2.1 Prescription Respiratory Drugs Revenue by Manufacturers (2015-2020) 3.2.2 Prescription Respiratory Drugs Revenue Share by Manufacturers (2015-2020) 3.2.3 Global Prescription Respiratory Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020) 3.2.4 Global Top 10 and Top 5 Companies by Prescription Respiratory Drugs Revenue in 2019 3.2.5 Global Prescription Respiratory Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Prescription Respiratory Drugs Price by Manufacturers 3.4 Prescription Respiratory Drugs Manufacturing Base Distribution, Product Types 3.4.1 Prescription Respiratory Drugs Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Prescription Respiratory Drugs Product Type 3.4.3 Date of International Manufacturers Enter into Prescription Respiratory Drugs Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026) 4.1 Global Prescription Respiratory Drugs Market Size by Type (2015-2020) 4.1.1 Global Prescription Respiratory Drugs Sales by Type (2015-2020) 4.1.2 Global Prescription Respiratory Drugs Revenue by Type (2015-2020) 4.1.3 Prescription Respiratory Drugs Average Selling Price (ASP) by Type (2015-2026) 4.2 Global Prescription Respiratory Drugs Market Size Forecast by Type (2021-2026) 4.2.1 Global Prescription Respiratory Drugs Sales Forecast by Type (2021-2026) 4.2.2 Global Prescription Respiratory Drugs Revenue Forecast by Type (2021-2026) 4.2.3 Prescription Respiratory Drugs Average Selling Price (ASP) Forecast by Type (2021-2026) 4.3 Global Prescription Respiratory Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End 5 Breakdown Data by Application (2015-2026) 5.1 Global Prescription Respiratory Drugs Market Size by Application (2015-2020) 5.1.1 Global Prescription Respiratory Drugs Sales by Application (2015-2020) 5.1.2 Global Prescription Respiratory Drugs Revenue by Application (2015-2020) 5.1.3 Prescription Respiratory Drugs Price by Application (2015-2020) 5.2 Prescription Respiratory Drugs Market Size Forecast by Application (2021-2026) 5.2.1 Global Prescription Respiratory Drugs Sales Forecast by Application (2021-2026) 5.2.2 Global Prescription Respiratory Drugs Revenue Forecast by Application (2021-2026) 5.2.3 Global Prescription Respiratory Drugs Price Forecast by Application (2021-2026) 6 North America 6.1 North America Prescription Respiratory Drugs by Country 6.1.1 North America Prescription Respiratory Drugs Sales by Country 6.1.2 North America Prescription Respiratory Drugs Revenue by Country 6.1.3 U.S. 6.1.4 Canada 6.2 North America Prescription Respiratory Drugs Market Facts & Figures by Type 6.3 North America Prescription Respiratory Drugs Market Facts & Figures by Application 7 Europe 7.1 Europe Prescription Respiratory Drugs by Country 7.1.1 Europe Prescription Respiratory Drugs Sales by Country 7.1.2 Europe Prescription Respiratory Drugs Revenue by Country 7.1.3 Germany 7.1.4 France 7.1.5 U.K. 7.1.6 Italy 7.1.7 Russia 7.2 Europe Prescription Respiratory Drugs Market Facts & Figures by Type 7.3 Europe Prescription Respiratory Drugs Market Facts & Figures by Application 8 Asia Pacific 8.1 Asia Pacific Prescription Respiratory Drugs by Region 8.1.1 Asia Pacific Prescription Respiratory Drugs Sales by Region 8.1.2 Asia Pacific Prescription Respiratory Drugs Revenue by Region 8.1.3 China 8.1.4 Japan 8.1.5 South Korea 8.1.6 India 8.1.7 Australia 8.1.8 Taiwan 8.1.9 Indonesia 8.1.10 Thailand 8.1.11 Malaysia 8.1.12 Philippines 8.1.13 Vietnam 8.2 Asia Pacific Prescription Respiratory Drugs Market Facts & Figures by Type 8.3 Asia Pacific Prescription Respiratory Drugs Market Facts & Figures by Application 9 Latin America 9.1 Latin America Prescription Respiratory Drugs by Country 9.1.1 Latin America Prescription Respiratory Drugs Sales by Country 9.1.2 Latin America Prescription Respiratory Drugs Revenue by Country 9.1.3 Mexico 9.1.4 Brazil 9.1.5 Argentina 9.2 Central & South America Prescription Respiratory Drugs Market Facts & Figures by Type 9.3 Central & South America Prescription Respiratory Drugs Market Facts & Figures by Application 10 Middle East and Africa 10.1 Middle East and Africa Prescription Respiratory Drugs by Country 10.1.1 Middle East and Africa Prescription Respiratory Drugs Sales by Country 10.1.2 Middle East and Africa Prescription Respiratory Drugs Revenue by Country 10.1.3 Turkey 10.1.4 Saudi Arabia 10.1.5 U.A.E 10.2 Middle East and Africa Prescription Respiratory Drugs Market Facts & Figures by Type 10.3 Middle East and Africa Prescription Respiratory Drugs Market Facts & Figures by Application 11 Company Profiles 11.1 AstraZeneca 11.1.1 AstraZeneca Corporation Information 11.1.2 AstraZeneca Description, Business Overview and Total Revenue 11.1.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020) 11.1.4 AstraZeneca Prescription Respiratory Drugs Products Offered 11.1.5 AstraZeneca Recent Development 11.2 Boehringer Ingelheim 11.2.1 Boehringer Ingelheim Corporation Information 11.2.2 Boehringer Ingelheim Description, Business Overview and Total Revenue 11.2.3 Boehringer Ingelheim Sales, Revenue and Gross Margin (2015-2020) 11.2.4 Boehringer Ingelheim Prescription Respiratory Drugs Products Offered 11.2.5 Boehringer Ingelheim Recent Development 11.3 GlaxoSmithKline 11.3.1 GlaxoSmithKline Corporation Information 11.3.2 GlaxoSmithKline Description, Business Overview and Total Revenue 11.3.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020) 11.3.4 GlaxoSmithKline Prescription Respiratory Drugs Products Offered 11.3.5 GlaxoSmithKline Recent Development 11.4 Merck 11.4.1 Merck Corporation Information 11.4.2 Merck Description, Business Overview and Total Revenue 11.4.3 Merck Sales, Revenue and Gross Margin (2015-2020) 11.4.4 Merck Prescription Respiratory Drugs Products Offered 11.4.5 Merck Recent Development 11.1 AstraZeneca 11.1.1 AstraZeneca Corporation Information 11.1.2 AstraZeneca Description, Business Overview and Total Revenue 11.1.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020) 11.1.4 AstraZeneca Prescription Respiratory Drugs Products Offered 11.1.5 AstraZeneca Recent Development 12 Future Forecast by Regions (Countries) (2021-2026) 12.1 Prescription Respiratory Drugs Market Estimates and Projections by Region 12.1.1 Global Prescription Respiratory Drugs Sales Forecast by Regions 2021-2026 12.1.2 Global Prescription Respiratory Drugs Revenue Forecast by Regions 2021-2026 12.2 North America Prescription Respiratory Drugs Market Size Forecast (2021-2026) 12.2.1 North America: Prescription Respiratory Drugs Sales Forecast (2021-2026) 12.2.2 North America: Prescription Respiratory Drugs Revenue Forecast (2021-2026) 12.2.3 North America: Prescription Respiratory Drugs Market Size Forecast by Country (2021-2026) 12.3 Europe Prescription Respiratory Drugs Market Size Forecast (2021-2026) 12.3.1 Europe: Prescription Respiratory Drugs Sales Forecast (2021-2026) 12.3.2 Europe: Prescription Respiratory Drugs Revenue Forecast (2021-2026) 12.3.3 Europe: Prescription Respiratory Drugs Market Size Forecast by Country (2021-2026) 12.4 Asia Pacific Prescription Respiratory Drugs Market Size Forecast (2021-2026) 12.4.1 Asia Pacific: Prescription Respiratory Drugs Sales Forecast (2021-2026) 12.4.2 Asia Pacific: Prescription Respiratory Drugs Revenue Forecast (2021-2026) 12.4.3 Asia Pacific: Prescription Respiratory Drugs Market Size Forecast by Region (2021-2026) 12.5 Latin America Prescription Respiratory Drugs Market Size Forecast (2021-2026) 12.5.1 Latin America: Prescription Respiratory Drugs Sales Forecast (2021-2026) 12.5.2 Latin America: Prescription Respiratory Drugs Revenue Forecast (2021-2026) 12.5.3 Latin America: Prescription Respiratory Drugs Market Size Forecast by Country (2021-2026) 12.6 Middle East and Africa Prescription Respiratory Drugs Market Size Forecast (2021-2026) 12.6.1 Middle East and Africa: Prescription Respiratory Drugs Sales Forecast (2021-2026) 12.6.2 Middle East and Africa: Prescription Respiratory Drugs Revenue Forecast (2021-2026) 12.6.3 Middle East and Africa: Prescription Respiratory Drugs Market Size Forecast by Country (2021-2026) 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Market Opportunities and Drivers 13.2 Market Challenges 13.3 Market Risks/Restraints 13.4 Porter’s Five Forces Analysis 13.5 Primary Interviews with Key Prescription Respiratory Drugs Players (Opinion Leaders) 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 Prescription Respiratory Drugs Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details

List of Tables Table 1. Prescription Respiratory Drugs Market Segments Table 2. Ranking of Global Top Prescription Respiratory Drugs Manufacturers by Revenue (US$ Million) in 2019 Table 3. Global Prescription Respiratory Drugs Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million) Table 4. Major Manufacturers of Anti-Inflammatories Table 5. Major Manufacturers of Mast Stabilizers Table 6. Major Manufacturers of Antihistamines Table 7. Major Manufacturers of Bronchodilators Table 8. Major Manufacturers of Other Respiratory Drugs Table 9. COVID-19 Impact Global Market: (Four Prescription Respiratory Drugs Market Size Forecast Scenarios) Table 10. Opportunities and Trends for Prescription Respiratory Drugs Players in the COVID-19 Landscape Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis Table 12. Key Regions/Countries Measures against Covid-19 Impact Table 13. Proposal for Prescription Respiratory Drugs Players to Combat Covid-19 Impact Table 14. Global Prescription Respiratory Drugs Market Size Growth Rate by Application 2020-2026 (K Units) Table 15. Global Prescription Respiratory Drugs Market Size by Region (K Units) & (US$ Million): 2020 VS 2026 Table 16. Global Prescription Respiratory Drugs Sales by Regions 2015-2020 (K Units) Table 17. Global Prescription Respiratory Drugs Sales Market Share by Regions (2015-2020) Table 18. Global Prescription Respiratory Drugs Revenue by Regions 2015-2020 (US$ Million) Table 19. Global Prescription Respiratory Drugs Sales by Manufacturers (2015-2020) (K Units) Table 20. Global Prescription Respiratory Drugs Sales Share by Manufacturers (2015-2020) Table 21. Global Prescription Respiratory Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020) Table 22. Global Prescription Respiratory Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prescription Respiratory Drugs as of 2019) Table 23. Prescription Respiratory Drugs Revenue by Manufacturers (2015-2020) (US$ Million) Table 24. Prescription Respiratory Drugs Revenue Share by Manufacturers (2015-2020) Table 25. Key Manufacturers Prescription Respiratory Drugs Price (2015-2020) (USD/Unit) Table 26. Prescription Respiratory Drugs Manufacturers Manufacturing Base Distribution and Headquarters Table 27. Manufacturers Prescription Respiratory Drugs Product Type Table 28. Date of International Manufacturers Enter into Prescription Respiratory Drugs Market Table 29. Manufacturers Mergers & Acquisitions, Expansion Plans Table 30. Global Prescription Respiratory Drugs Sales by Type (2015-2020) (K Units) Table 31. Global Prescription Respiratory Drugs Sales Share by Type (2015-2020) Table 32. Global Prescription Respiratory Drugs Revenue by Type (2015-2020) (US$ Million) Table 33. Global Prescription Respiratory Drugs Revenue Share by Type (2015-2020) Table 34. Prescription Respiratory Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/Unit) Table 35. Global Prescription Respiratory Drugs Sales by Application (2015-2020) (K Units) Table 36. Global Prescription Respiratory Drugs Sales Share by Application (2015-2020) Table 37. North America Prescription Respiratory Drugs Sales by Country (2015-2020) (K Units) Table 38. North America Prescription Respiratory Drugs Sales Market Share by Country (2015-2020) Table 39. North America Prescription Respiratory Drugs Revenue by Country (2015-2020) (US$ Million) Table 40. North America Prescription Respiratory Drugs Revenue Market Share by Country (2015-2020) Table 41. North America Prescription Respiratory Drugs Sales by Type (2015-2020) (K Units) Table 42. North America Prescription Respiratory Drugs Sales Market Share by Type (2015-2020) Table 43. North America Prescription Respiratory Drugs Sales by Application (2015-2020) (K Units) Table 44. North America Prescription Respiratory Drugs Sales Market Share by Application (2015-2020) Table 45. Europe Prescription Respiratory Drugs Sales by Country (2015-2020) (K Units) Table 46. Europe Prescription Respiratory Drugs Sales Market Share by Country (2015-2020) Table 47. Europe Prescription Respiratory Drugs Revenue by Country (2015-2020) (US$ Million) Table 48. Europe Prescription Respiratory Drugs Revenue Market Share by Country (2015-2020) Table 49. Europe Prescription Respiratory Drugs Sales by Type (2015-2020) (K Units) Table 50. Europe Prescription Respiratory Drugs Sales Market Share by Type (2015-2020) Table 51. Europe Prescription Respiratory Drugs Sales by Application (2015-2020) (K Units) Table 52. Europe Prescription Respiratory Drugs Sales Market Share by Application (2015-2020) Table 53. Asia Pacific Prescription Respiratory Drugs Sales by Region (2015-2020) (K Units) Table 54. Asia Pacific Prescription Respiratory Drugs Sales Market Share by Region (2015-2020) Table 55. Asia Pacific Prescription Respiratory Drugs Revenue by Region (2015-2020) (US$ Million) Table 56. Asia Pacific Prescription Respiratory Drugs Revenue Market Share by Region (2015-2020) Table 57. Asia Pacific Prescription Respiratory Drugs Sales by Type (2015-2020) (K Units) Table 58. Asia Pacific Prescription Respiratory Drugs Sales Market Share by Type (2015-2020) Table 59. Asia Pacific Prescription Respiratory Drugs Sales by Application (2015-2020) (K Units) Table 60. Asia Pacific Prescription Respiratory Drugs Sales Market Share by Application (2015-2020) Table 61. Latin America Prescription Respiratory Drugs Sales by Country (2015-2020) (K Units) Table 62. Latin America Prescription Respiratory Drugs Sales Market Share by Country (2015-2020) Table 63. Latin Americaa Prescription Respiratory Drugs Revenue by Country (2015-2020) (US$ Million) Table 64. Latin America Prescription Respiratory Drugs Revenue Market Share by Country (2015-2020) Table 65. Latin America Prescription Respiratory Drugs Sales by Type (2015-2020) (K Units) Table 66. Latin America Prescription Respiratory Drugs Sales Market Share by Type (2015-2020) Table 67. Latin America Prescription Respiratory Drugs Sales by Application (2015-2020) (K Units) Table 68. Latin America Prescription Respiratory Drugs Sales Market Share by Application (2015-2020) Table 69. Middle East and Africa Prescription Respiratory Drugs Sales by Country (2015-2020) (K Units) Table 70. Middle East and Africa Prescription Respiratory Drugs Sales Market Share by Country (2015-2020) Table 71. Middle East and Africa Prescription Respiratory Drugs Revenue by Country (2015-2020) (US$ Million) Table 72. Middle East and Africa Prescription Respiratory Drugs Revenue Market Share by Country (2015-2020) Table 73. Middle East and Africa Prescription Respiratory Drugs Sales by Type (2015-2020) (K Units) Table 74. Middle East and Africa Prescription Respiratory Drugs Sales Market Share by Type (2015-2020) Table 75. Middle East and Africa Prescription Respiratory Drugs Sales by Application (2015-2020) (K Units) Table 76. Middle East and Africa Prescription Respiratory Drugs Sales Market Share by Application (2015-2020) Table 77. AstraZeneca Corporation Information Table 78. AstraZeneca Description and Major Businesses Table 79. AstraZeneca Prescription Respiratory Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 80. AstraZeneca Product Table 81. AstraZeneca Recent Development Table 82. Boehringer Ingelheim Corporation Information Table 83. Boehringer Ingelheim Description and Major Businesses Table 84. Boehringer Ingelheim Prescription Respiratory Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 85. Boehringer Ingelheim Product Table 86. Boehringer Ingelheim Recent Development Table 87. GlaxoSmithKline Corporation Information Table 88. GlaxoSmithKline Description and Major Businesses Table 89. GlaxoSmithKline Prescription Respiratory Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 90. GlaxoSmithKline Product Table 91. GlaxoSmithKline Recent Development Table 92. Merck Corporation Information Table 93. Merck Description and Major Businesses Table 94. Merck Prescription Respiratory Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 95. Merck Product Table 96. Merck Recent Development Table 97. Global Prescription Respiratory Drugs Sales Forecast by Regions (2021-2026) (K Units) Table 98. Global Prescription Respiratory Drugs Sales Market Share Forecast by Regions (2021-2026) Table 99. Global Prescription Respiratory Drugs Revenue Forecast by Regions (2021-2026) (US$ Million) Table 100. Global Prescription Respiratory Drugs Revenue Market Share Forecast by Regions (2021-2026) Table 101. North America: Prescription Respiratory Drugs Sales Forecast by Country (2021-2026) (K Units) Table 102. North America: Prescription Respiratory Drugs Revenue Forecast by Country (2021-2026) (US$ Million) Table 103. Europe: Prescription Respiratory Drugs Sales Forecast by Country (2021-2026) (K Units) Table 104. Europe: Prescription Respiratory Drugs Revenue Forecast by Country (2021-2026) (US$ Million) Table 105. Asia Pacific: Prescription Respiratory Drugs Sales Forecast by Region (2021-2026) (K Units) Table 106. Asia Pacific: Prescription Respiratory Drugs Revenue Forecast by Region (2021-2026) (US$ Million) Table 107. Latin America: Prescription Respiratory Drugs Sales Forecast by Country (2021-2026) (K Units) Table 108. Latin America: Prescription Respiratory Drugs Revenue Forecast by Country (2021-2026) (US$ Million) Table 109. Middle East and Africa: Prescription Respiratory Drugs Sales Forecast by Country (2021-2026) (K Units) Table 110. Middle East and Africa: Prescription Respiratory Drugs Revenue Forecast by Country (2021-2026) (US$ Million) Table 111. Key Opportunities and Drivers: Impact Analysis (2021-2026) Table 112. Key Challenges Table 113. Market Risks Table 114. Main Points Interviewed from Key Prescription Respiratory Drugs Players Table 115. Prescription Respiratory Drugs Customers List Table 116. Prescription Respiratory Drugs Distributors List Table 117. Research Programs/Design for This Report Table 118. Key Data Information from Secondary Sources Table 119. Key Data Information from Primary Sources List of Figures Figure 1. Prescription Respiratory Drugs Product Picture Figure 2. Global Prescription Respiratory Drugs Sales Market Share by Type in 2020 & 2026 Figure 3. Anti-Inflammatories Product Picture Figure 4. Mast Stabilizers Product Picture Figure 5. Antihistamines Product Picture Figure 6. Bronchodilators Product Picture Figure 7. Other Respiratory Drugs Product Picture Figure 8. Global Prescription Respiratory Drugs Sales Market Share by Application in 2020 & 2026 Figure 9. Hospital Pharmacies Figure 10. Drug Stores Figure 11. Retail Stores Figure 12. E-Commerce Figure 13. Prescription Respiratory Drugs Report Years Considered Figure 14. Global Prescription Respiratory Drugs Market Size 2015-2026 (US$ Million) Figure 15. Global Prescription Respiratory Drugs Sales 2015-2026 (K Units) Figure 16. Global Prescription Respiratory Drugs Market Size Market Share by Region: 2020 Versus 2026 Figure 17. Global Prescription Respiratory Drugs Sales Market Share by Region (2015-2020) Figure 18. Global Prescription Respiratory Drugs Sales Market Share by Region in 2019 Figure 19. Global Prescription Respiratory Drugs Revenue Market Share by Region (2015-2020) Figure 20. Global Prescription Respiratory Drugs Revenue Market Share by Region in 2019 Figure 21. Global Prescription Respiratory Drugs Sales Share by Manufacturer in 2019 Figure 22. The Top 10 and 5 Players Market Share by Prescription Respiratory Drugs Revenue in 2019 Figure 23. Prescription Respiratory Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 24. Global Prescription Respiratory Drugs Sales Market Share by Type (2015-2020) Figure 25. Global Prescription Respiratory Drugs Sales Market Share by Type in 2019 Figure 26. Global Prescription Respiratory Drugs Revenue Market Share by Type (2015-2020) Figure 27. Global Prescription Respiratory Drugs Revenue Market Share by Type in 2019 Figure 28. Global Prescription Respiratory Drugs Market Share by Price Range (2015-2020) Figure 29. Global Prescription Respiratory Drugs Sales Market Share by Application (2015-2020) Figure 30. Global Prescription Respiratory Drugs Sales Market Share by Application in 2019 Figure 31. Global Prescription Respiratory Drugs Revenue Market Share by Application (2015-2020) Figure 32. Global Prescription Respiratory Drugs Revenue Market Share by Application in 2019 Figure 33. North America Prescription Respiratory Drugs Sales Growth Rate 2015-2020 (K Units) Figure 34. North America Prescription Respiratory Drugs Revenue Growth Rate 2015-2020 (US$ Million) Figure 35. North America Prescription Respiratory Drugs Sales Market Share by Country in 2019 Figure 36. North America Prescription Respiratory Drugs Revenue Market Share by Country in 2019 Figure 37. U.S. Prescription Respiratory Drugs Sales Growth Rate (2015-2020) (K Units) Figure 38. U.S. Prescription Respiratory Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 39. Canada Prescription Respiratory Drugs Sales Growth Rate (2015-2020) (K Units) Figure 40. Canada Prescription Respiratory Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 41. North America Prescription Respiratory Drugs Market Share by Type in 2019 Figure 42. North America Prescription Respiratory Drugs Market Share by Application in 2019 Figure 43. Europe Prescription Respiratory Drugs Sales Growth Rate 2015-2020 (K Units) Figure 44. Europe Prescription Respiratory Drugs Revenue Growth Rate 2015-2020 (US$ Million) Figure 45. Europe Prescription Respiratory Drugs Sales Market Share by Country in 2019 Figure 46. Europe Prescription Respiratory Drugs Revenue Market Share by Country in 2019 Figure 47. Germany Prescription Respiratory Drugs Sales Growth Rate (2015-2020) (K Units) Figure 48. Germany Prescription Respiratory Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 49. France Prescription Respiratory Drugs Sales Growth Rate (2015-2020) (K Units) Figure 50. France Prescription Respiratory Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 51. U.K. Prescription Respiratory Drugs Sales Growth Rate (2015-2020) (K Units) Figure 52. U.K. Prescription Respiratory Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 53. Italy Prescription Respiratory Drugs Sales Growth Rate (2015-2020) (K Units) Figure 54. Italy Prescription Respiratory Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 55. Russia Prescription Respiratory Drugs Sales Growth Rate (2015-2020) (K Units) Figure 56. Russia Prescription Respiratory Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 57. Europe Prescription Respiratory Drugs Market Share by Type in 2019 Figure 58. Europe Prescription Respiratory Drugs Market Share by Application in 2019 Figure 59. Asia Pacific Prescription Respiratory Drugs Sales Growth Rate 2015-2020 (K Units) Figure 60. Asia Pacific Prescription Respiratory Drugs Revenue Growth Rate 2015-2020 (US$ Million) Figure 61. Asia Pacific Prescription Respiratory Drugs Sales Market Share by Region in 2019 Figure 62. Asia Pacific Prescription Respiratory Drugs Revenue Market Share by Region in 2019 Figure 63. China Prescription Respiratory Drugs Sales Growth Rate (2015-2020) (K Units) Figure 64. China Prescription Respiratory Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 65. Japan Prescription Respiratory Drugs Sales Growth Rate (2015-2020) (K Units) Figure 66. Japan Prescription Respiratory Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 67. South Korea Prescription Respiratory Drugs Sales Growth Rate (2015-2020) (K Units) Figure 68. South Korea Prescription Respiratory Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 69. India Prescription Respiratory Drugs Sales Growth Rate (2015-2020) (K Units) Figure 70. India Prescription Respiratory Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 71. Australia Prescription Respiratory Drugs Sales Growth Rate (2015-2020) (K Units) Figure 72. Australia Prescription Respiratory Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 73. Taiwan Prescription Respiratory Drugs Sales Growth Rate (2015-2020) (K Units) Figure 74. Taiwan Prescription Respiratory Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 75. Indonesia Prescription Respiratory Drugs Sales Growth Rate (2015-2020) (K Units) Figure 76. Indonesia Prescription Respiratory Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 77. Thailand Prescription Respiratory Drugs Sales Growth Rate (2015-2020) (K Units) Figure 78. Thailand Prescription Respiratory Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 79. Malaysia Prescription Respiratory Drugs Sales Growth Rate (2015-2020) (K Units) Figure 80. Malaysia Prescription Respiratory Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 81. Philippines Prescription Respiratory Drugs Sales Growth Rate (2015-2020) (K Units) Figure 82. Philippines Prescription Respiratory Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 83. Vietnam Prescription Respiratory Drugs Sales Growth Rate (2015-2020) (K Units) Figure 84. Vietnam Prescription Respiratory Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 85. Asia Pacific Prescription Respiratory Drugs Market Share by Type in 2019 Figure 86. Asia Pacific Prescription Respiratory Drugs Market Share by Application in 2019 Figure 87. Latin America Prescription Respiratory Drugs Sales Growth Rate 2015-2020 (K Units) Figure 88. Latin America Prescription Respiratory Drugs Revenue Growth Rate 2015-2020 (US$ Million) Figure 89. Latin America Prescription Respiratory Drugs Sales Market Share by Country in 2019 Figure 90. Latin America Prescription Respiratory Drugs Revenue Market Share by Country in 2019 Figure 91. Mexico Prescription Respiratory Drugs Sales Growth Rate (2015-2020) (K Units) Figure 92. Mexico Prescription Respiratory Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 93. Brazil Prescription Respiratory Drugs Sales Growth Rate (2015-2020) (K Units) Figure 94. Brazil Prescription Respiratory Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 95. Argentina Prescription Respiratory Drugs Sales Growth Rate (2015-2020) (K Units) Figure 96. Argentina Prescription Respiratory Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 97. Latin America Prescription Respiratory Drugs Market Share by Type in 2019 Figure 98. Latin America Prescription Respiratory Drugs Market Share by Application in 2019 Figure 99. Middle East and Africa Prescription Respiratory Drugs Sales Growth Rate 2015-2020 (K Units) Figure 100. Middle East and Africa Prescription Respiratory Drugs Revenue Growth Rate 2015-2020 (US$ Million) Figure 101. Middle East and Africa Prescription Respiratory Drugs Sales Market Share by Country in 2019 Figure 102. Middle East and Africa Prescription Respiratory Drugs Revenue Market Share by Country in 2019 Figure 103. Turkey Prescription Respiratory Drugs Sales Growth Rate (2015-2020) (K Units) Figure 104. Turkey Prescription Respiratory Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 105. Saudi Arabia Prescription Respiratory Drugs Sales Growth Rate (2015-2020) (K Units) Figure 106. Saudi Arabia Prescription Respiratory Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 107. U.A.E Prescription Respiratory Drugs Sales Growth Rate (2015-2020) (K Units) Figure 108. U.A.E Prescription Respiratory Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 109. Middle East and Africa Prescription Respiratory Drugs Market Share by Type in 2019 Figure 110. Middle East and Africa Prescription Respiratory Drugs Market Share by Application in 2019 Figure 111. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018 Figure 112. Boehringer Ingelheim Total Revenue (US$ Million): 2019 Compared with 2018 Figure 113. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018 Figure 114. Merck Total Revenue (US$ Million): 2019 Compared with 2018 Figure 115. North America Prescription Respiratory Drugs Sales Growth Rate Forecast (2021-2026) (K Units) Figure 116. North America Prescription Respiratory Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million) Figure 117. Europe Prescription Respiratory Drugs Sales Growth Rate Forecast (2021-2026) (K Units) Figure 118. Europe Prescription Respiratory Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million) Figure 119. Asia Pacific Prescription Respiratory Drugs Sales Growth Rate Forecast (2021-2026) (K Units) Figure 120. Asia Pacific Prescription Respiratory Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million) Figure 121. Latin America Prescription Respiratory Drugs Sales Growth Rate Forecast (2021-2026) (K Units) Figure 122. Latin America Prescription Respiratory Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million) Figure 123. Middle East and Africa Prescription Respiratory Drugs Sales Growth Rate Forecast (2021-2026) (K Units) Figure 124. Middle East and Africa Prescription Respiratory Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million) Figure 125. Porter's Five Forces Analysis Figure 126. Channels of Distribution Figure 127. Distributors Profiles Figure 128. Bottom-up and Top-down Approaches for This Report Figure 129. Data Triangulation Figure 130. Key Executives Interviewed


What's Included

  • Market Size
  • Market Share
  • Market Segmentation
  • Market Forecast
  • Regional Segment Analysis
  • Compound Annual Growth Rate
  • Company & Brand Details
  • Market Revenue and Growth Opportunities
  • Safe and Secure

FAQ's

By product type
By End User/Applications
By Technology
By Leading Industry Players
By Region
We will send you an email with login credentials to access the report. You will also be able to download the pdf.
The study on the impact of COVID-19 on the global market is classified into different segments and analysed based on regions, including North America, Europe, Asia-Pacific, and Rest of World.

Report ID :1301383

Published Date :24 July 2020

Category :Pharmaceuticals and Healthcare

Pages :115 Pages

Why Choose Us

  • Lowest Price Guarantee
  • We offer the lowest prices for the listed reports

  • Data Security
  • Your data is safe and secure

  • Vast Report Database
  • We have more than 2 Million reports in our database

  • Client Focused
  • Personalized updates and 24*7 support

  • Trusted Source and Quality
  • We only work with reputable partners providing high quality research and support

  • Market Segmentation
  • We provide alternative views of the market to help you identify where the real opportunities lie

  • Bulk Discounts
  • We offer great discounts on purchase of multiple reports



Every Sample Will Help to Understand

  • Report Structure and Outline
  • Detailed Table of Content (Including List of Tables and Figures)
  • Research Methodology

Report ID :1301383

Published Date :24 July 2020

Category :Pharmaceuticals and Healthcare

Pages :115 Pages

Why Choose Us

  • Lowest Price Guarantee
  • We offer the lowest prices for the listed reports

  • Data Security
  • Your data is safe and secure

  • Vast Report Database
  • We have more than 2 Million reports in our database

  • Client Focused
  • Personalized updates and 24*7 support

  • Trusted Source and Quality
  • We only work with reputable partners providing high quality research and support

  • Market Segmentation
  • We provide alternative views of the market to help you identify where the real opportunities lie

  • Bulk Discounts
  • We offer great discounts on purchase of multiple reports



COVID-19 Impact on Global Prescription Respiratory Drugs Market Insights, Forecast to 2026

Request COVID-19 Impact Analysis

We understand the economic repercussions of the pandemic and are dedicated towards helping our clients strategize with rapidly changing market scenario,
  • Impact of COVID on supply/demand scenario, trade landscape & supply chain
  • How market participants are preparing/strategizing to combat the impact
  • How does the short-term & long-term scenario for Prescription Respiratory Drugs Market looks like

Report ID :1301383

Published Date :24 July 2020

Category :Pharmaceuticals and Healthcare

Pages :115 Pages

Why Choose Us

  • Lowest Price Guarantee
  • We offer the lowest prices for the listed reports


  • Data Security
  • Your data is safe and secure


  • Vast Report Database
  • We have more than 2 Million reports in our database


  • Client Focused
  • Personalized updates and 24*7 support


  • Trusted Source and Quality
  • We only work with reputable partners providing high quality research and support


  • Market Segmentation
  • We provide alternative views of the market to help you identify where the real opportunities lie


  • Bulk Discounts
  • We offer great discounts on purchase of multiple reports